These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33936642)

  • 1. A community pharmacist's intervention in antipsychotic drug-induced sexual dysfunction in a patient with schizophrenia.
    Maehara M; Sugiyama M
    Clin Case Rep; 2021 Apr; 9(4):2074-2076. PubMed ID: 33936642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacists' liability into the year 2000.
    Lynn NJ; Ellis JM
    J Am Pharm Assoc (Wash); 1998; 38(6):747-52; quiz 753-4. PubMed ID: 9861793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between the pharmacist's role, patient understanding and satisfaction during the provision of a cost-effective pharmacist-led intervention.
    Manfrin A
    J Eval Clin Pract; 2023 Aug; 29(5):825-835. PubMed ID: 37171399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public's attitudes towards community pharmacy in Qatar: a pilot study.
    El Hajj MS; Salem S; Mansoor H
    Patient Prefer Adherence; 2011; 5():405-22. PubMed ID: 21949604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacist's perspective regarding patient-centred communication in conjunction with pharmaceutical practice: A cross-sectional survey.
    Rusu A; Chereches MC; Popa C; Botezatu R; Lungu IA; Moldovan OL
    Saudi Pharm J; 2022 Sep; 30(9):1327-1344. PubMed ID: 36249938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
    Aghili M; Neelathahalli Kasturirangan M
    JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing community pharmacists' likelihood to ask medication monitoring questions: A factorial survey.
    Witry MJ; Doucette WR
    Res Social Adm Pharm; 2015; 11(5):639-50. PubMed ID: 25573019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of pharmacist's intervention in the management of cardiovascular diseases.
    Omboni S; Caserini M
    Open Heart; 2018; 5(1):e000687. PubMed ID: 29344376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacy detection of erectile dysfunction in men with risk factors or who seek treatment or advice but lack a valid prescription.
    Martin Morales A; Hatzichristou D; Ramon Lladós J; Pascual Renedo V; Pimenidou A
    J Sex Med; 2013 Sep; 10(9):2303-11. PubMed ID: 23845082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing relationships: attitudes and opinions of general practitioners and pharmacists regarding the role of the community pharmacist.
    Muijrers PE; Knottnerus JA; Sijbrandij J; Janknegt R; Grol RP
    Pharm World Sci; 2003 Oct; 25(5):235-41. PubMed ID: 14584231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Evaluation of the Belgian Community Pharmacist's Satisfaction with the Implementation of the Electronic Prescription Within a Pharmacist's Software.
    Van Laere S; Cornu P; Buyl R
    Stud Health Technol Inform; 2019 Aug; 264():1884-1885. PubMed ID: 31438391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What doctors expect of a pharmacist's work--how a pharmacist is evaluated by doctors].
    Matsumoto Y; Shimizu M; Fukuoka M
    Yakugaku Zasshi; 2003 Mar; 123(3):173-8. PubMed ID: 12693018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to pay for a pharmacist's dispensing service: a cross-sectional pilot study in the state of Penang, Malaysia.
    Shafie AA; Hassali MA
    Pharm Pract (Granada); 2010 Apr; 8(2):116-21. PubMed ID: 25132879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on the pharmacist's "product": a narrative review.
    Holdford DA
    Pharm Pract (Granada); 2021; 19(2):2430. PubMed ID: 34188731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Drug-Drug Interactions among Critically Ill Patients with Chronic Kidney Disease: Impact of Clinical Pharmacist's Interventions.
    Aghili M; Kasturirangan MN
    Indian J Crit Care Med; 2021 Nov; 25(11):1226-1231. PubMed ID: 34866818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute stroke in patients taking an oral anticoagulant: impact of clinical pharmacist's intervention on pharmacovigilance reporting.
    Thillard EM; Rousselière C; Béné J; Caparros F; Bodenant M; Odou P; Gautier S; Décaudin B
    Acta Clin Belg; 2023 Dec; 78(6):478-485. PubMed ID: 37746693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacist's interventions in factors contributing to medication errors reduces medication errors in self-management of patients in the rehabilitation ward.
    Suzuki R; Uchiya T; Sakai T; Takahashi M; Ohtsu F
    J Pharm Health Care Sci; 2022 Dec; 8(1):37. PubMed ID: 36510270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the community pharmacist's behavior towards a prescription of antidiabetic and antiasthma drugs.
    Alomar MJ; Qandil S; Al-Hilwani HM; Malkat DM; Caroline C
    Pharm Pract (Granada); 2011 Jan; 9(1):37-43. PubMed ID: 25132888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived Roles of Independent Community Pharmacists and Pharmacy Technicians in Patient Referrals to Community Resources: A Study from the Medication Safety Research Network of Indiana (Rx-SafeNet).
    Miller RG; Perras CA; Frail CK; Adeoye OA; Snyder ME
    J Am Coll Clin Pharm; 2019 Aug; 2(4):383-401. PubMed ID: 31460498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time and motion study of pharmacist prescribing of oral hormonal contraceptives in Oregon community pharmacies.
    Frost TP; Klepser DG; Small DC; Doyle IC
    J Am Pharm Assoc (2003); 2019; 59(2):222-227. PubMed ID: 30745187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.